Clinical Trial

Implementation of Family Psychosocial Risk Assessment in Pediatric Cancer

Study acronym: PAT
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The diagnosis and treatment of pediatric cancer adversely affects multiple levels of the social ecology, including patient and caregiver physical and psychosocial health. It is the strong recommendation from the first Standard of the Psychosocial Standards of Care in Pediatric Cancer that cancer centers engage in universal, systematic, psychosocial risk screening for newly diagnosed patients and their families. Universal screening at diagnosis fosters early identification of psychosocial risks and provides the opportunity to match psychosocial care to the level of family need for more equitable, effective and integrated services. However, few programs offer such care in an efficient, comprehensive, and consistent manner, potentially resulting in insufficient care that magnifies inequities in outcomes. To support pediatric cancer centers in their goal of meeting the first Standard of Psychosocial Care, this study will compare two implementation strategies for the Psychosocial Assessment Tool (PAT), a validated parent report screener of family psychosocial risk in English and Spanish, in a cluster randomized trial across 18 pediatric cancer programs in the United States.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2020-06-23; most recent amendment 2025-12-22.
Status change: Recruiting → Active, Not Recruiting 2023-03-15
Status change: Not Yet Recruiting → Recruiting 2021-09-01
Trial Details
NCT Number NCT04446728
Lead Sponsor Nemours Children's Clinic
Collaborators: Children's Hospital of Philadelphia, American Cancer Society, Inc.
Conditions Pediatric Cancer
Enrollment 18 participants
Start Date 2021-01-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-30